How Pharma Can Adjust to Primary Care’s Future Today

Drastic change is overtaking primary care. However, how pharma markets to primary care physicians ...

Collaborate With Physicians!

Pharmaceutical companies invest enormous resources and take enormous risks to make the products that ...

Adherence: The Next “Blockbuster”

While the day of the blockbuster pill died with Lipitor going generic, the days ...

Can Pharma and Physicians Engage Meaningfully?

It’s the holy grail for pharmaceutical executives. Physician engagement—the ability to achieve a meaningful ...

It Is All About Caring

Getting people to do things—like take their medicine—is a personal thing. Mechanical interactions—like beeps, ...

Taking the Doctor Out of the Equation

As influential as the pharmaceutical industry can be, the most influential player in prescription ...

When the “Digital Physician” is Just the…Physician

As an industry, we continue to talk about “digital” as a unique channel as ...

Putting Risk into Proper Perspective

A few years ago when my wife and I bought our home, we found ...

Just Plain Smart HCP Communications

As we all know, much has been written about the benefits of multi-channel communications. ...

Is There a Doctor In-House?

A combination of conflict of interest concerns, public disclosure via the Sunshine Act and—particularly ...

PM360 Q&A with John Theobald, CEO, Healthcasts

John Theobald could be said to be a maverick. Starting with his first entrepreneurial ...

Ineffective Drug Versus Poor Adherence

In the world of dermatology, topical corticosteroids are the most widely used treatments. They ...